MondayFeb 13, 2023 9:45 am

BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) COVID-19 NanoAb Takes Centerstage at the 2023 BIO CEO & Investor Conference

Amir Reichman, BiondVax CEO, represented the company at this year’s BIO CEO & Investor Conference held at the Marriott Marquis, New York, on February 6-8 His presentation focused on the company’s recent successful pre-clinical in vivo results on its innovative inhaled COVID-19 treatment Additional results from the study were release in January 2023, indicating that, compared to the control group, hamsters that received the drug one day after infection had negligible SARS-CoV-2 vital titers in their lungs and experienced a significantly milder and shorter illness BiondVax’s management is optimistic that its self-administered inhaled NanoAbs will be highly attractive to at-risk…

Continue Reading

MondayFeb 13, 2023 9:00 am

SideChannel Inc. (SDCH) Strengthens Your Organization’s Security Posture with its vCISO Service and the Application of Enclave and RealCISO Technology

SideChannel, a company on a mission to make cybersecurity simple and accessible to company of all sizes, believes that a secure network begins with segmentation, an approach made possible by the offering of vCISOs, together with the application of RealCISO and Enclave technology RealCISO allows SideChannel to perform an important initial security audit to identify your organization’s current security posture Enclave simplifies microsegmentation - a network security tactic that shrinks your organization's attack surface SideChannel (OTCQB: SDCH) believes that all companies should be able to easily, and affordably, understand and manage cyber risk. It also believes that a secure network…

Continue Reading

FridayFeb 10, 2023 10:30 am

Purposeful Earth Stewardship Drives Innovation for Luxury B&B Brand Developer Coyuchi Inc.

Coyuchi Inc. is a California-based bed and bath lifestyle brand focused on sustainable practices and producing comfortable, organic products The company had a net income of $1.4 million on sales of $33 million last year Coyuchi is expanding its product line with two new items sourced from cotton that the company helped grow as part of a collaborative, soil-rejuvenating project last year The company launched a Reg A+ investment offering last year and announced that capital raised had topped $1 million by the end of the year In a recent podcast interview, the company’s CEO and president outlined Coyuchi’s priorities…

Continue Reading

FridayFeb 10, 2023 9:45 am

Sharing Services Global Corp. (SHRG) Dedicated to Developing Opportunities in Growing Direct-Selling Space

A new report projects that the global direct-selling establishments market size will grow from $688.45 billion in 2022 to $763.85 billion in 2023 SHRG is focused on positioning itself to take advantage of projected growth The company has developed opportunities in several spaces, including the health and wellness, travel, and restaurant sectors In a market forecast to see almost $80 billion growth (https://ibn.fm/7ZJfu), Sharing Services Global (OTCQB: SHRG) is working to offer a variety of options for its brand partners, subscribers and independent sales force. SHRG operates in the direct-selling space, where it is dedicated to developing or acquiring businesses,…

Continue Reading

FridayFeb 10, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expecting Additional Growth in 2023, Including IND Filing and IND Clinical Study

In addition to a recently released shareholder update letter from the company’s CEO, Chris Bunka, Lexaria Bioscience has now released a new investor presentation Despite 2022 inflationary conditions, Lexaria has seen growth company-wide – including hitting annual budgets +/- 2% over the last two years Lexaria’s patented DehydraTECH(TM) technology offers more effective delivery of active pharmaceutical ingredients into the bloodstream and brain tissue with 28 patents granted and roughly 50 patent applications pending worldwide For Q1 2023, Lexaria expects additional results from its hypertension study HYPER-H21-4, dosing completion in its animal dementia study and diabetes study, dosing completion in human…

Continue Reading

ThursdayFeb 09, 2023 10:30 am

Nemaura Medical, Inc. (NASDAQ: NMRD) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference

Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT(R), a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (“CGM”) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT(R) to the U.S. FDA. proBEAT(TM) combines non-invasive glucose data processed using artificial intelligence and a digital healthcare…

Continue Reading

ThursdayFeb 09, 2023 9:45 am

Utopia VR Pioneers ‘Metaverse-As-A-Service’, Seeks to Revolutionize the Workplace as We Know It

The modern workplace has undergone a radical shift in recent years, moving increasingly away from an office-centric model towards a more hybrid working environment Corporate employees are revealing they are increasingly spending more time in meetings, with over 77% of these taking place online Users can host and attend meetings in lifelike virtual reality – with no software downloads – engaging their audiences in a more collaborative and fun way In April 2022, the company launched the world’s first web-based, mobile-friendly, audio and video conference platform Early on Tuesday 8th January 2019, WeWork announced that the company had successfully concluded…

Continue Reading

ThursdayFeb 09, 2023 9:00 am

REZYFi, Inc. Provides the Cannabis Industry with Critical Financing Options and Services Still Not Available with Traditional Banking Institutions

Cannabis businesses continue to face challenges finding opportunities for financing despite the continued drive for legalization REZYFi is pivotal providing much-needed support to the cannabis industry through two wholly owned subsidiaries – REZYFi Lending and ResMac Inc. For 2023, combined cannabis industry sales are projected to reach $38.8 billion In recent years, the cannabis industry has seen significant changes – with 39 states legalizing cannabis for medicinal use and 21 states allowing recreational use. For 2023, the combined sales are projected to reach $38.8 billion for the industry (https://ibn.fm/dqo2m). In spite of this significant growth, there is a challenge that…

Continue Reading

WednesdayFeb 08, 2023 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Commissions Demonstration Plant; Plans for Louisiana Strategic Metals Complex

Ucore’s RapidSX(TM) Demonstration Plant will be located within the company’s 5000 square foot Commercialization and Demonstration Facility in Kingston, Ontario A Strategic Metals Complex is being planned in Louisiana with an initial capacity of 2,000 tonnes per annum and increasing to production of 5,000 tonnes Cerium, neodymium, lanthanum, praseodymium, yttrium, and dysprosium are expected to remain the most sought-after REEs, with high demands in magnet manufacturing and the automobile industry The global rare earth element market was valued at $2.8 billion in 2018 and is expected to grow at a CAGR of 10.4% through 2025 Ucore Rare Metals (TSX.V: UCU)…

Continue Reading

WednesdayFeb 08, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Encouraged by Nanosized Antibody Study Results as Market Forecasts Predict Rapid Growth

Market analysts predict monoclonal antibodies (“mAbs”) will be the fastest-growing revenue segment of the biologics medicinal market through the end of the decade BiondVax Pharmaceuticals is focused on developing and commercializing novel mAb “biobetter” NanoAbs to meet underserved medical needs addressing large market disorders The company’s recent work with an inhaled nanosized antibody for COVID has shown exceptionally promising results, virtually preventing illness and eliminating the SARS-COV-2 virus in a hamster population With COVID as first target, the company’s pipeline aims to provide effective medical responses to other disorders such asthma, psoriasis, psoriatic arthritis, and macular degeneration Immunotherapeutic product innovator…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered